Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment
In multiple myeloma impressive outcomes have improved with the introduction of new therapeutic approaches, mainly those including naked monoclonal antibodies such as daratumumab and isatuximab. However, moving to earlier lines of therapy with effective anti-myeloma drugs led to an increase in the nu...
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
MDPI AG
2023-11-01
|
| Sraith: | Pharmaceuticals |
| Ábhair: | |
| Rochtain ar líne: | https://www.mdpi.com/1424-8247/16/11/1628 |